Invention Grant
- Patent Title: Substituted quinoxalines as B-raf kinase inhibitors
- Patent Title (中): 取代喹喔啉作为B-raf激酶抑制剂
-
Application No.: US14346692Application Date: 2012-09-20
-
Publication No.: US09249110B2Publication Date: 2016-02-02
- Inventor: Xiangping Qian , Yong-Liang Zhu
- Applicant: NEUPHARMA, INC.
- Applicant Address: US CA Foster City
- Assignee: NEUPHARMA, INC.
- Current Assignee: NEUPHARMA, INC.
- Current Assignee Address: US CA Foster City
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2012/056432 WO 20120920
- International Announcement: WO2013/043935 WO 20130328
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D241/42 ; A61K31/5377 ; C12Q1/68 ; G01N33/574
Abstract:
Described herein are kinase inhibitors represented by Formula I: and pharmaceutical compositions thereof for use in the treatment of cancer.
Public/Granted literature
- US20150057276A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Public/Granted day:2015-02-26
Information query
IPC分类:
